Angelman syndrome (AS) is a rare genetic disorder that primarily affects the nervous system, leading to severe developmental delays, intellectual disabilities, and a distinctive set of physical and behavioral characteristics. First described by British pediatrician Dr. Harry Angelman in 1965, this condition affects approximately 1 in 12,000 to 20,000 people